Cargando…

Decoding TROP2 in breast cancer: significance, clinical implications, and therapeutic advancements

Breast cancer is a heterogeneous disease characterized by distinct molecular subtypes, varied prognoses, and differential treatment responses. Understanding the molecular landscape and identifying therapeutic targets, such as trophoblast cell-surface antigen 2 (TROP2), is vital. TROP2 is notably ove...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Liqin, Chen, Junfeng, Ma, Wenxue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635515/ https://www.ncbi.nlm.nih.gov/pubmed/37954074 http://dx.doi.org/10.3389/fonc.2023.1292211

Ejemplares similares

Clinicopathologic significance of TROP2 and phospho-TROP2 in gastric cancer
por: Kushiyama, Shuhei, et al.
Publicado: (2021)

Trop2 and its overexpression in cancers: regulation and clinical/therapeutic implications
por: Shvartsur, Anna, et al.
Publicado: (2015)

Trop-2 as a Therapeutic Target in Breast Cancer
por: Sakach, Elizabeth, et al.
Publicado: (2022)

A non-mutated TROP2 fingerprint in cancer genetics
por: Guerra, Emanuela, et al.
Publicado: (2023)

Expression and clinical significance of the Trop-2 gene in advanced non-small cell lung carcinoma
por: JIANG, AIGUI, et al.
Publicado: (2013)

Decoding Melanoma Development and Progression: Identification of Therapeutic Vulnerabilities
por: Eddy, Kevinn, et al.
Publicado: (2021)

Toxicarioside O Inhibits Cell Proliferation and Epithelial-Mesenchymal Transition by Downregulation of Trop2 in Lung Cancer Cells
por: Zheng, Wu-Ping, et al.
Publicado: (2021)

Trop-2 Is a Determinant of Breast Cancer Survival
por: Ambrogi, Federico, et al.
Publicado: (2014)

Assessing Current Therapeutic Approaches to Decode Potential Resistance Mechanisms in Glioblastomas
por: Sze, Chun-I, et al.
Publicado: (2013)

Alteration of Trop-2 expression in breast cancer cells by clinically used therapeutic agents and acquired tamoxifen resistance
por: Zhu, Jing, et al.
Publicado: (2022)

Genomic Alteration Burden in Advanced Prostate Cancer and Therapeutic Implications
por: Ryan, Matthew J., et al.
Publicado: (2019)

Clinical Implications of ESR1 Mutations in Hormone Receptor-Positive Advanced Breast Cancer
por: Reinert, Tomas, et al.
Publicado: (2017)

Correction: Trop-2 Is a Determinant of Breast Cancer Survival
Publicado: (2014)

TROP2 methylation and expression in tamoxifen-resistant breast cancer
por: Zimmers, Stephanie M., et al.
Publicado: (2018)

TROP2 as Patient-Tailoring but Not Prognostic Biomarker for Breast Cancer
por: Liu, Xiaoyue, et al.
Publicado: (2022)

The Regulation Network and Clinical Significance of Circular RNAs in Breast Cancer
por: Xu, Juan, et al.
Publicado: (2021)

Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer
por: Sperger, Jamie M., et al.
Publicado: (2023)

Functional and Therapeutic Significance of Tumor-Associated Macrophages in Colorectal Cancer
por: Li, Yitong, et al.
Publicado: (2022)

Decoding the Therapeutic Implications of the ERα Stability and Subcellular Distribution in Breast Cancer
por: Tecalco-Cruz, Angeles C., et al.
Publicado: (2022)

Antibody-drug conjugates targeting TROP-2: Clinical development in metastatic breast cancer
por: Shastry, Mythili, et al.
Publicado: (2022)

Stem Cells and Cellular Origins of Breast Cancer: Updates in the Rationale, Controversies, and Therapeutic Implications
por: Zhou, Jiaojiao, et al.
Publicado: (2019)

Epigenetically upregulating TROP2 and SLFN11 enhances therapeutic efficacy of TROP2 antibody drug conjugate sacitizumab govitecan
por: Zhao, Ming, et al.
Publicado: (2023)

Significance of EpCAM and TROP2 expression in non-small cell lung cancer
por: Pak, Min Gyoung, et al.
Publicado: (2012)

Clinical significance of enlarged cardiophrenic lymph nodes by CT in advanced ovarian cancer
por: Song, Sisi, et al.
Publicado: (2023)

Head-to-Head Comparison of the Expression Differences of NECTIN-4, TROP-2, and HER2 in Urothelial Carcinoma and Its Histologic Variants
por: Fan, Yu, et al.
Publicado: (2022)

Heterotypic Cellular Interactions in the Ovarian Tumor Microenvironment: Biological Significance and Therapeutic Implications
por: Naora, Honami
Publicado: (2014)

Clinical implications and immune implications features of TARS1 in breast cancer
por: Gui, Zhengwei, et al.
Publicado: (2023)

Advanced diagnostic and therapeutic strategies in nanotechnology for lung cancer
por: Duan, Yujuan, et al.
Publicado: (2022)

Trop-2 protein as a therapeutic target: A focused review on Trop-2-based antibody-drug conjugates and their predictive biomarkers
por: Vranic, Semir, et al.
Publicado: (2022)

Advances in Rodent Models for Breast Cancer Formation, Progression, and Therapeutic Testing
por: Liu, Chong, et al.
Publicado: (2021)

Correlation of TROP-2 expression with clinical–pathological characteristics and outcome in triple-negative breast cancer
por: Izci, Hava, et al.
Publicado: (2022)

Antibody-drug conjugates targeting Trop-2: Clinical developments in early breast cancer therapy
por: Jeong, Jae Ho, et al.
Publicado: (2022)

Clinical Significance of Elevated S100A8 Expression in Breast Cancer Patients
por: Wang, Dujuan, et al.
Publicado: (2018)

PIWI-interacting RNAs in cancer: Biogenesis, function, and clinical significance
por: Yao, Jie, et al.
Publicado: (2022)

Breast Cancer Patients: Who Would Benefit from Neoadjuvant Chemotherapies?
por: Yao, Liqin, et al.
Publicado: (2022)

Breast cancer liver metastasis: Pathogenesis and clinical implications
por: Liu, Cuiwei, et al.
Publicado: (2022)

The expression and clinical significance of GADD45A in breast cancer patients
por: Wang, Junnan, et al.
Publicado: (2018)

Expression Patterns of Ezrin and AJAP1 and Clinical Significance in Breast Cancer
por: Xu, Cong, et al.
Publicado: (2022)

The Significance of TROP2 Expression in Predicting BRAF Mutations in Papillary Thyroid Carcinoma
por: Kong, Joon Seog, et al.
Publicado: (2018)

Role of the Glyoxalase System in Breast Cancer and Gynecological Cancer-Implications for Therapeutic Intervention: a Review
por: Wang, Jingyuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h5qbm9aesjpnolfau8uvncacch